Allele-specific quantification of human leukocyte antigen transcript isoforms by nanopore sequencing.
allele-specific expression
human leukocyte antigen (HLA)
long-read sequencing
nanopore sequencing
transcript isoforms
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
04
2023
accepted:
05
07
2023
medline:
5
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
While tens of thousands of HLA alleles have been identified by DNA sequencing, the contribution of alternative splicing to HLA diversity is not well characterized. In this study, we sought to determine if long-read sequencing could be used to accurately quantify allele-specific HLA transcripts in primary human lymphocytes. cDNA libraries were prepared from peripheral blood lymphocytes from 12 donors and sequenced by nanopore long-read sequencing. HLA reads were aligned to donor-specific reference sequences based on the known type of each donor. Allele-specific exon utilization was calculated as the proportion of reads aligning to each allele containing known exons, and transcript isoforms were quantified based on patterns of exon utilization within individual reads. Splice variants were rare among class I HLA genes (median exon retention rate 99%-100%), except for several We describe a simple bioinformatic workflow to quantify allele-specific expression of HLA transcript isoforms. Further studies are warranted to characterize the repertoire of HLA transcripts expressed in different cell types and tissues across diverse populations.
Identifiants
pubmed: 37662944
doi: 10.3389/fimmu.2023.1199618
pmc: PMC10471969
doi:
Substances chimiques
RNA Splice Sites
0
Histocompatibility Antigens
0
Histocompatibility Antigens Class II
0
Protein Isoforms
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1199618Informations de copyright
Copyright © 2023 Hughes, Montgomery, Liu and Weimer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Hum Immunol. 2021 Apr;82(4):288-295
pubmed: 33612390
J Am Soc Nephrol. 2018 Oct;29(10):2482-2492
pubmed: 30185468
PLoS Comput Biol. 2018 Aug 17;14(8):e1006360
pubmed: 30118475
Mol Psychiatry. 2020 Jan;25(1):37-47
pubmed: 31695164
Immunogenetics. 1988;27(3):203-10
pubmed: 3276619
HLA. 2022 Sep;100(3):232-243
pubmed: 35650170
PLoS One. 2013 Jun 24;8(6):e66883
pubmed: 23826166
Hum Immunol. 2021 Jul;82(7):488-495
pubmed: 32386782
Nat Commun. 2019 Jul 31;10(1):3359
pubmed: 31366910
Nat Methods. 2019 Dec;16(12):1297-1305
pubmed: 31740818
Hum Mol Genet. 2004 Dec 15;13(24):3189-202
pubmed: 15496424
J Mol Diagn. 2020 Jan;22(1):101-110
pubmed: 31669229
Nucleic Acids Res. 2020 Jan 8;48(D1):D948-D955
pubmed: 31667505
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Nat Methods. 2013 Dec;10(12):1177-84
pubmed: 24185837
Immunogenetics. 1992;36(5):319-25
pubmed: 1644449
Curr Genomics. 2017 Jun;18(3):268-277
pubmed: 28659722
Sci Rep. 2019 Oct 17;9(1):14908
pubmed: 31624302
Hum Immunol. 2021 Apr;82(4):296-301
pubmed: 33676750
Nature. 2012 Sep 6;489(7414):101-8
pubmed: 22955620
Hum Immunol. 1998 Jul;59(7):387-403
pubmed: 9684989
Nat Methods. 2016 Sep;13(9):792-8
pubmed: 27502218
J Mol Diagn. 2018 Jul;20(4):428-435
pubmed: 29625249
Nat Biotechnol. 2014 Sep;32(9):903-14
pubmed: 25150838
Nat Commun. 2017 Jul 19;8:16027
pubmed: 28722025
Proc Natl Acad Sci U S A. 1989 Feb;86(3):1003-7
pubmed: 2464826
J Immunol. 2006 Feb 15;176(4):2381-8
pubmed: 16455996
Tissue Antigens. 2004 Jan;63(1):58-71
pubmed: 14651525
J Exp Med. 1986 May 1;163(5):1173-90
pubmed: 3701253
F1000Res. 2016 Mar 17;5:
pubmed: 27006762
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Front Genet. 2022 Jun 13;13:901377
pubmed: 35879986